Overview: Strong knowledge of data structures and recognizing common patterns makes complex coding questions easier and faster to solve.Thinking out loud during ...

Goose acts as the agent that plans, iterates, and applies changes. Ollama is the local runtime that hosts the model. Qwen3-coder is the coding-focused LLM that generates results. If you've been ...

LinkedIn is making vibe coding skills a more prominent part of user profiles. (LinkedIn) LinkedIn has long been a platform for showing off professional accomplishments. Now, the company is leaning ...

LinkedIn has just announced a team-up with three vibe-coding platforms – Lovable, Relay.app, and Replit – that will give users the ability to connect their coding accounts with their LinkedIn account.

CNBC tested the Chinese AI startup Zhipu's new coding tool, and found it just as impressive as American AI coding agents. AI insiders told CNBC that Zhipu's GLM 4.7 model is gaining recognition in the ...

AI coding tools are rapidly changing how we produce software, and the industry is embracing it—perhaps at the expense of entry-level coding jobs. Generative AI’s ability to write software code has ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...